Scientific journal
Fundamental research
ISSN 1812-7339
"Перечень" ВАК
ИФ РИНЦ = 1,674

Personal portfolio

Features of thyroid status patients with atrial fibrillation in combination with anemic syndrome

Bugrova I.A. 1 Mayskova E.A. 2 Shvarts Y.G. 2
1 Clinical Hospital n.a. S.R Mirotvortseva SGMU, Saratov
2 GBOU VPO «Saratov State Medical University n.a V.I. Razumovskogo» Minzdravsocrazvitija of Russia, Saratov
A total of 110 patients with cardiovascular diseases (70 with atrial fibrillation (AF), 40 – no rhythm disturbances) were examined. The investigation of hemoglobin, red blood cells, thyroid hormones, antithyroid antibodies and C-reactive protein (CRP) were done. In patients with a combination of AF and anemia observed the highest levels of free thriiodothyronine and anti TPO in comparison with patients who had AF at normal levels of red blood cells and hemoglobin (р < 0,05). Also, there was a tendency to increase in rates of free thyroxine and thyroid-stimulating hormone in patients with atrial fibrillation and anemia. Thus, the combination of pathologies (AF + anemia) there is increased activity of the thyroid gland, with indirect signs of functional autonomy. Increased activity of the thyroid was not accompanied by increased levels of inflammatory marker CRP. Given the ability of thyroid hormone enhance hemopoiesis is likely to increase the activity of thyroid is a response to anemia.
atrial fibrillation
anemia
thyroid gland
1. M.I. Balabolkin, E.M. Klebanova, V.M. Kreminskaja Fundamental’naja i klinicheskaja tiroidologija [fundamental and clinical tiroidologiya], Moscow, 2007, pp. 543–546.
2. T.M. Uskach, A.G. Kochetov, S.N.Terewenko Kliniko-statisticheskij analiz rasprostranennosti anemii u pacientov s hronicheskoj serdechnoj nedostatochnost’ju [сlinico-statistical analysis of the prevalence of anemia in patients with chronic heart failure], Kardiologija-Cardiology, 2011, no 1, pp. 11–17.
3. Patologija krovi: patofiziologicheskie i klinicheskie aspekty [Blood pathology: pathophysiology and clinical aspects ] N.P. Chesnokova, A.V. Mihajlov i dr. Saratov, 2002, pp. 44–48.
4. Opredelenie znachenija anemii v prognoze recidiva ostrogo infarkta miokarda [Determining the value of anemia in the prediction of relapse of acute myocardial infarction ] Ju.G. Shwarts, T.Ju. Kaljuta, R.N. Karimov i dr. Kardiovaskuljarnaja praktika- Cardiovascular Practice , 2006, no. 4, pp. 65–69.
5. Khaud A., Cleland J., Deedwania P. Heart Fail. Rev. 2002. Vol. 7. рр. 267–283.
6. Meneveau N., Schiele F., Seronde M.F., Descotes-Genon V., Oettinger J., Chopard R., Ecarnot F., Bassand J.P. Anemia for Risk Assessment of Patients With Acute Coronary Syndromes, Am J Cardiol. 2009. Vol. 103. рр. 442– 447.
7. Pereira A.A., Sarnak M.J. Anemia as a risk factor for cardiovascular disease KidneyIntSuppl., 2003, рр. 32–39.
8. Sarnak M.J., Tighiouart H., Manjunath G., et al. Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study // J Am Coll Cardiol. 2002. Vol. 40. рр. 27–33.
9. SavelievaI., Camm A. // Oxford J. Med. 2003. Vol. 5 (1). рр. 5–19.
10. Zeidman A., Fradin Z., Blecher A., Oster H.S., Avrahami Y. Mittelman M.Anemia as a Risk Factor for Ischemic Heart Disease, IMAJ. 2004. Vol. 6. рр. 16–18.

Рецензенты:

Олейников В.Э., д.м.н., профессор, заведующий кафедрой внутренних болезней медицинского факультета Пензенского государственного университета, г. Пенза;

Лямина Н.П., д.м.н., профессор, заместитель директора по научной работе ФГБУ «Саратовский научно-исследовательский институт кардиологии» Минздравсоцразвития России, г. Саратов.

Работа поступила в редакцию 25.06.2012